Home › B-cel lymfoom › New York › New York City
B-cel lymfoom klinische studies in New York City, NY
18 studies voor B-cel lymfoom zoeken deelnemers op locaties in en rond New York City (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
RekruterenFase 3
- Memorial Sloan Kettering Cancer Center Mskcc, New York
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RekruterenFase 1
- New York University (NYU) Clinical Cancer Center, New York
- Weill Cornell Medicine, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
RekruterenFase 1/2
- Icahn School of Medicine At Mount Sinai, New York
- Columbia University Medical Center, New York
- Weill Cornell Medical College Newyork Presbyterian Hospital, New York
- en nog 1
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
RekruterenFase 2
- Research Site, New York
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
RekruterenFase 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
RekruterenFase 1/2
- Research Site, New York
A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
RekruterenFase 1
- Clinical Trial Site, New York
- Clinical Trial Site, New York
A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
RekruterenFase 1/2
- Research Site, New York
A Study of ARC-02 in B-cell NHL
RekruterenFase 1
- NYU Langone, New York
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RekruterenFase 1/2
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies
RekruterenFase 1/2
- Research Site, New York
DALY II USA/ MB-CART2019.1 for DLBCL
RekruterenFase 2
- Memorial Sloan Kettering Cancer Center, New York
A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
RekruterenFase 1/2
- Memorial Sloan Kettering, New York
Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)
RekruterenFase 2
- Columbia University Irving Medical Center, New York
Study of CAR-T Therapy in Older Patients
RekruterenObservatieonderzoek
- Memorial Sloan Kettering Cancer Center, New York
ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL
Rekruteren
- Columbia University, New York
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
Rekruteren
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
- NEW YORK PRESBYTERIAN HOSPITAL (Data Collection Only), New York
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RekruterenFase 1
- Children's Hospital New York-Presbyterian, New York
- Memorial Sloan Kettering Cancer Center, New York
B-cel lymfoom studies in andere steden
- Houston, TX16 studies
- Chicago, IL13 studies
- Nashville, TN11 studies
- Philadelphia, PA11 studies
- Rochester, MN10 studies
- Baldwin Park, CA9 studies
- Cleveland, OH9 studies
- Milwaukee, WI9 studies
- Salt Lake City, UT8 studies
- Boston, MA8 studies
- Washington, DC7 studies
- Pittsburgh, PA7 studies
Andere studies in New York City
- Borstkanker137 studies
- Niet-kleincellige longkanker121 studies
- Kanker (alle vormen)110 studies
- Prostaatkanker102 studies
- Metastatische kanker93 studies
- Colorectale kanker78 studies
- Eierstokkanker70 studies
- Aldermeesklierkanker60 studies
- Multipel myeloom60 studies
- Longkanker60 studies
- Endometriumkanker52 studies
- Hartfalen51 studies
Van ClinicalTrials.gov, gegevens opgehaald op 7 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.